Persistence Market Research

Cardiac Rhythm Management Market: Global Industry Analysis and Forecast to 2020

Persistence Market Research Pvt. Ltd is released new forthcoming report on title "Cardiac Rhythm Management Market: Global Industry Analysis and Forecast to 2020".

 

New York, NY -- (SBWIRE) -- 12/05/2014 -- Cardiac rhythm management refers to a process for monitoring the proper functioning of heart with the help of cardiac rhythm management devices. Cardiac rhythm management device is used to provide therapeutic solutions to patients suffering from cardiac disorders. Cardiac disorder includes cardiac arrhythmias, heart failure and cardiac arrests. Cardiac disorders cause irregular heartbeat. Technological advancement, rise in number of deaths due to heart diseases and increasing aging population are some of the main factors that are driving the cardiac rhythm management market. Heart disease is one of the main causes of death in the U.S. Excess of alcohol consumption, smoking, high cholesterol levels and obesity are some of the major causes of heart disease. Cardiac rhythm management includes two main products such as implantable cardiac rhythm devices and pacemakers. Implantable cardiac rhythm devices treat patients with improper heartbeat. On the basis of devices, cardiac rhythm management market can be segmented into defibrillators, pacemakers, cardiac resynchronization therapy devices, implantable defibrillators and external defibrillators. Pacemaker helps to treat patients with slow heart beats. On the basis of end users, cardiac rhythm management market can be segmented into hospitals, home/ambulatory and others.

Buy Full Report:
http://www.persistencemarketresearch.com/market-research/cardiac-rhythm-management-market.asp

North America, followed by Europe, has the largest market for cardiac rhythm management due to developed healthcare infrastructure, government initiatives, rise in incidence of cardiac disorders, growing number of deaths due to cardiovascular diseases and increasing healthcare expenditure in the region. Asia is expected to experience high growth rate in the cardiac rhythm management market in next few years due to increasing incidence of cardiovascular diseases, growing disposable income, rise in awareness about heart disorders and its treatments and developing healthcare infrastructure in the region.

Increasing prevalence of cardiovascular diseases, technological advancement, rise in life expectancy, increasing awareness about cardiac disorders and government initiatives are some of the major factors that are expected to drive the market for cardiac rhythm management. In addition, rise in disposable income, increasing aging population and high cost of heart disease treatment is expected to drive the market for cardiac rhythm management. However, economic downturn, reimbursement issues, importance of biologics and stem cells and inappropriate use of the devices are some of the factors restraining the growth for global cardiac rhythm management market.

Growing demographics and economies in the developing countries such as India and China is expected to lead the growth in cardiac rhythm management market in Asia. In addition, innovations along with technological advancement such as MRI pacemakers, miniaturization, biocompatible materials and durable batteries, continuous rise in aging population and increasing cardiovascular diseases such as arrhythmias, stroke and high blood pressure are expected to offer new opportunities for global cardiac rhythm management market. Increasing number of mergers and acquisitions, rise in number of collaborations and partnerships and new product launches are some of the latest trends that have been observed in global cardiac rhythm management market. Some of the major companies operating in the global cardiac rhythm management market are Medtronic, Abbott Laboratories, Boston Scientific, St Jude Medical, Altera and Sorin. Some other companies having significant presence in the global cardiac rhythm management market are Biotronik, Mentice AB, Philips Healthcare, GE Healthcare, 3M pharmaceuticals, Guidant and ELA Medical.

Request Full TOC:
http://www.persistencemarketresearch.com/toc/3868

Key points covered in the report:

1) Report segments the market on the basis of types, application, products, technology, etc (as applicable)

2) The report covers geographic segmentation
North America
Europe
Asia
RoW

3) The report provides the market size and forecast for the different segments and geographies for the period of 2010 to 2020

4) The report provides company profiles of some of the leading companies operating in the market

5) The report also provides porters five forces analysis of the market.

About Persistence Market Research
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

PMR stands committed to bringing more accuracy and speed to clients' business decisions. From ready-to-purchase market research reports to customized research solutions, PMR's engagement models are highly flexible without compromising on its deep-seated research values.